Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors

被引:44
作者
Greinix, HT
Faé, I
Schneider, B
Rosenmayr, A
Mitterschiffthaler, A
Pelzmann, B
Kalhs, P
Lechner, K
Mayr, WR
Fischer, GF
机构
[1] Med Univ Vienna, Dept Med 1, Vienna, Austria
[2] Med Univ Vienna, Dept Blood Grp Serol, Vienna, Austria
[3] Univ Vienna, Inst Med Stat & Documentat, A-1010 Vienna, Austria
[4] Austrian Bone Marrow Donor Registry, Vienna, Austria
关键词
HLA class I; high resolution typing; chronic GVHD;
D O I
10.1038/sj.bmt.1704741
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
There is consensus that matching of unrelated donors (URD) and patients for HLA class II alleles improves the outcome of hematopoietic stem cell transplantation (HSCT). However, the significance of HLA class I allelic mismatches for transplant outcome is under discussion and reports on long-term effects like chronic graft-versus-host disease (GVHD) a re rare. Thus, we investigated the association of human leukocyte antigen (HLA) class I allele mismatches and outcome in 144 patients given HSCT from URD who were matched for HLA-DRB1, DRB3/4/5, and DQB1 alleles. The risk of chronic GVHD was significantly increased in patients with class I mismatched donors, the mismatch either detected by low- or high-resolution typing. A single HLA class I allele mismatch significantly increased the risk of chronic GVHD in multivariate analysis. Overall survival was significantly reduced in patient/donor pairs with more than one-allele class I mismatch. Thus, selection of unrelated donors for transplantation should be based on high-resolution HLA class I typing.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 27 条
[1]   HLA-DR, DQ, AND OR DP GENOTYPIC MISMATCHES BETWEEN RECIPIENT-DONOR PAIRS IN UNRELATED BONE-MARROW TRANSPLANTATION AND TRANSPLANT CLINICAL OUTCOME [J].
ALDACCAK, R ;
LOISEAU, P ;
RABIAN, C ;
DEVERGIE, A ;
BOURDEAU, H ;
RAFFOUX, C ;
GLUCKMAN, E ;
COLOMBANI, J .
TRANSPLANTATION, 1990, 50 (06) :960-964
[2]   BONE-MARROW TRANSPLANTATION [J].
ARMITAGE, JO .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (12) :827-838
[3]   A COMBINATION OF 2 DISTINCT IN-VITRO AMPLIFICATION PROCEDURES FOR DNA TYPING OF HLA-DRB AND HLA-DQB1 ALLELES [J].
FISCHER, GF ;
FAE, I ;
PETRASEK, M ;
MOSER, S .
VOX SANGUINIS, 1995, 69 (04) :328-335
[4]  
Fischer GF, 1998, TISSUE ANTIGENS, V51, P312
[5]  
FLOMENBERG N, 2004, BLOOD 0610
[6]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[7]   Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia [J].
Hansen, JA ;
Gooley, TA ;
Martin, PJ ;
Appelbaum, F ;
Chauncey, TR ;
Clift, RA ;
Petersdorf, EW ;
Radich, J ;
Sanders, JE ;
Storb, RF ;
Sullivan, KM ;
Anasetti, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (14) :962-968
[8]   ANALYSIS OF 462 TRANSPLANTATIONS FROM UNRELATED DONORS FACILITATED BY THE NATIONAL-MARROW-DONOR-PROGRAM [J].
KERNAN, NA ;
BARTSCH, G ;
ASH, RC ;
BEATTY, PG ;
CHAMPLIN, R ;
FILIPOVICH, A ;
GAJEWSKI, J ;
HANSEN, JA ;
HENSLEEDOWNEY, J ;
MCCULLOUGH, J ;
MCGLAVE, P ;
PERKINS, HA ;
PHILLIPS, GL ;
SANDERS, J ;
STRONCEK, D ;
THOMAS, ED ;
BLUME, KG .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (09) :593-602
[9]   Factors influencing the outcome of bone marrow transplants using unrelated donors [J].
Madrigal, JA ;
Scott, I ;
Arguello, R ;
Szydlo, R ;
Little, AM ;
Goldman, JM .
IMMUNOLOGICAL REVIEWS, 1997, 157 :153-166
[10]  
MCGLAVE P, 1993, BLOOD, V81, P543